The role of BTK inhibitors in MCL, ongoing trials & future

The role of BTK inhibitors in MCL, ongoing trials & future outlooks: updates from EHA 2024

Listen now

Description

The introduction of Bruton’s tyrosine kinase (BTK) inhibitors into the treatment landscape for mantle cell lymphoma (MCL) has transformed the...

More Episodes

This week’s podcast features discussions on the use of immunotherapy in the treatment of high-risk multiple myeloma (HRMM) from the...

Published 11/12/24

Published 11/12/24

This podcast features a discussion from the 6th International Workshop on Acute Leukemias (iwAL) 2024, which took place in Phoenix,...

Published 11/06/24